Treatment Options in HER2+ eBC Breast Cancer
Treatment Options in HER2+ eBC Breast Cancer
Scripps MD Anderson Cancer Center
Treatment Approaches of HER2+ mBC
FEATURING
Joanne Mortimer
- 93 views
- September 4, 2023
OncoAlert
Anti-HER2 (non-ADC) Therapy in Treatment of HER2+- BC: Current Clinical Evidence
FEATURING
Cristina Saura
- 148 views
- July 5, 2023
- 2
Houston Methodist Hospital
Biology-Driven De-Escalation of Therapy in HER2+ BC
FEATURING
Polly Niravath
- 139 views
- August 29, 2023
- 1
OncoAlert
Anti-HER2 (non-ADC) Therapy in Treatment of HER2+- BC: Integration With RT
FEATURING
Sara Alkner
- 48 views
- July 5, 2023
Yale Cancer Center
De-Escalation of Adjuvant Therapy in Early Stage HER2+ Breast Cancers
FEATURING
Lajos Pusztai
- 818 views
- June 28, 2023
- 6
ecancer
ASCO® 2023 Insights: "PHERGain Data on Dual HER2 Blockade Without Chemo in Early Stage BC"
FEATURING
Javier Cortes
- 209 views
- June 15, 2023
- 3
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials Including NATALEE & PHERGain"
FEATURING
Hope Rugo,
Komal Jhaveri
- 4,412 views
- June 9, 2023
- 17
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Are We Splitting HERs? The Highs and Lows"
FEATURING
David Rimm
- 216 views
- June 8, 2023
- 4
2023 Best of Breast Conference
Optimizing Treatment in Early Stage HER2+ BC
FEATURING
Reshma L. Mahtani
- 300 views
- February 16, 2023
- 1
Dana-Farber Cancer Institute
Updates on the Personalized Management of HER2+ eBC for 2023
FEATURING
Adrienne Waks
- 81 views
- May 31, 2023